Washington, DC (PRWEB) February 12, 2016
Atlantic Information Services, Inc. (AIS) is pleased to announce “Managing High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health plans and PBMs are employing strategies to maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat cholesterol.
Steve Avey, vice president, specialty pharmacy, for MedImpact Healthcare Systems, Inc., and Josh Golden, practice leader, employer consulting, with Pharmaceutical Strategies Group LLC, will discuss the various strategies being deployed in some of these high-cost categories and their financial results. Participants will:
- Hear how the hepatitis C “price wars” changed the landscape for negotiating rebates and making formulary decisions, especially as new PCSK9 inhibitors enter the market.
- Learn how MedImpact uses a scientific, evidence-based approach to ensure that the right patient gets the right drug at the right time.
- Gain insights into strategies other PBMs and their clients have adopted to manage high-cost drugs and what results they are achieving.
- Learn what major pipeline developments for hepatitis C, cancer and other big-dollar categories are on the way and how they can impact a health plan or PBM’s bottom line.
Visit https://aishealth.com/marketplace/c6p06_022416 for more details and registration information.
Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for nearly 30 years. It develops highly targeted news, data and strategic information for managers in hospitals and health systems, health insurance companies, medical group practices, purchasers of health insurance, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, databases, websites, looseleafs, strategic reports, directories, webinars and virtual conferences.